Posted by u/AustroInvestor 5 minutes ago Purcha
Post# of 148282
(Total Views: 410)
Posted On: 09/30/2021 10:12:01 AM
Posted by
u/AustroInvestor
5 minutes ago
Purchases from the Philipines
Opinion
When I heard yesterday about purchases around 300k by now, I thought thats not much allthough I liked that more and more are coming. My second thought today is that depending on how much they charge per vial, LL should have saved about 100 more patients over there considering a 4 doses approach. My third thought right now is, that I start understanding Nader‘s excitement. The Chances for EUA in the Philipines rise with every life saved! And purchases are growing, thus more lives are saved. In my opinion we do have two different approaches on track: classical trial approach in Brazil and the CSP path towards an EUA in the Philippines. Lets see where EUA happens first. My excitement is growing!
Comment as jumpinthewatersdeep
This illustrates very clearly why I keep beating the drum to "Stay The Course"
The third front is the anecdotal evidence growing out of the cancer sectors (see the post shared by me from Mark S)
Having oncologists witness monotherapy usage of Leronlimab in their patients and being floored by the positive results will light fires that will not be extinguished.
I am tempted to say I won't bore you with all the other potentialities, but they shouldn't bore you or anyone. Still, brevity will let this sink in easier.
u/AustroInvestor
5 minutes ago
Purchases from the Philipines
Opinion
When I heard yesterday about purchases around 300k by now, I thought thats not much allthough I liked that more and more are coming. My second thought today is that depending on how much they charge per vial, LL should have saved about 100 more patients over there considering a 4 doses approach. My third thought right now is, that I start understanding Nader‘s excitement. The Chances for EUA in the Philipines rise with every life saved! And purchases are growing, thus more lives are saved. In my opinion we do have two different approaches on track: classical trial approach in Brazil and the CSP path towards an EUA in the Philippines. Lets see where EUA happens first. My excitement is growing!
Comment as jumpinthewatersdeep
This illustrates very clearly why I keep beating the drum to "Stay The Course"
The third front is the anecdotal evidence growing out of the cancer sectors (see the post shared by me from Mark S)
Having oncologists witness monotherapy usage of Leronlimab in their patients and being floored by the positive results will light fires that will not be extinguished.
I am tempted to say I won't bore you with all the other potentialities, but they shouldn't bore you or anyone. Still, brevity will let this sink in easier.
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼